Bioequivalence Study for Acarbose / Metformin FDC

NCT01728740 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type II

Interventions

DRUG: Acarbose/Metformin FDC (BAY81-9783)
DRUG: Acarbose (Glucobay, BAYG5421)
DRUG: Metformin

Sponsor

Bayer